Completed PHASE4 INTERVENTIONAL 2-arm NCT00642434

Comparison of Blood Pressure Medications on Metabolism

Carvedilol vs.Metoprolol: A Comparison of Effects on Endothelial Function and Oxidative Stress in Response to Acute Hyperglycemia in Patients With Type 2 Diabetes and Hypertension

Sponsor: University of New Mexico

Conditions Diabetes

Interventions carvedilol metoprolol

Updated 7 times since 2017 Last updated: Dec 7, 2023 Started: Jan 31, 2004 Primary completion: Jun 30, 2008 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00642434, this PHASE4 trial focuses on Diabetes and remains completed. Sponsored by University of New Mexico, it has been updated 7 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2024 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jan 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of New Mexico

Data source: University of New Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Albuquerque, United States